I am surprised it is done before the EGM officially approves the issue of the shares that exceed the 10-15% annual "allowance".
$70m+ in cash, assuming 2-2.5b SoI, cash backed at about 3-3.5c. Like CHM, the market values the company as almost ZERO, what a great level to invest from. Yes, huge dilution but the other option could have been bankruptcy or selling for 0.1c per share. Now Lantheus is in charge, it will get taken to the US over time and a new subsidiary for Lantheus is in the making. Hopper puts $3m of his own money into it and hasn't sold any IMU or CHM shares so far. He wouldn't do that if there wasn't any upside. Anyone, do yourself a favour and check out how the Centro-Group got re-started. From $10 to 1c, then the bank diluted all retail out and shortly after that rapt in billions. A similar scenario will play out here too, a retail held stock transformed into a insto held stock, exactly what Hopper always wanted. Could have been achieved on the way up at high costs to all instos involved or on the way down, costing hardly anything. Which way would you have chosen if you were Hopper?
GLTA
- Forums
- ASX - By Stock
- Ann: Radiopharm Theranostics completes A$70 million placement
I am surprised it is done before the EGM officially approves the...
Featured News
Add RAD (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.7¢ |
Change
0.003(12.5%) |
Mkt cap ! $58.66M |
Open | High | Low | Value | Volume |
2.5¢ | 2.7¢ | 2.5¢ | $69.50K | 2.674M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 2.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.7¢ | 596103 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100000 | 0.026 |
4 | 876524 | 0.025 |
2 | 1528000 | 0.024 |
5 | 733171 | 0.023 |
6 | 3570454 | 0.022 |
Price($) | Vol. | No. |
---|---|---|
0.027 | 596103 | 4 |
0.028 | 645678 | 2 |
0.029 | 614616 | 2 |
0.030 | 956342 | 5 |
0.031 | 1059676 | 3 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
RAD (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online